Net Cash Provided by (Used in) Operating Activities |
10.3K |
USD |
+505% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
700K |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
10.3K |
USD |
+505% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
806 |
USD |
-61% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
503 |
USD |
-38.3% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
45.1K |
USD |
+6.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
45.1K |
USD |
+6.3% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
63.6K |
USD |
0% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
2.96K |
USD |
-21% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |